WallStreetZen

NYSE: ZTS
Zoetis Inc Stock Forecast, Predictions & Price Target

Analyst price target for ZTS

Based on 6 analysts offering 12 month price targets for Zoetis Inc.
Min Forecast
$180.00-19.27%
Avg Forecast
$214.67-3.72%
Max Forecast
$264.00+18.4%

Should I buy or sell ZTS stock?

Based on 7 analysts offering ratings for Zoetis Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
1 analysts 14.29%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ZTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 4%
97
Strong BuyInitiates Coverage On$264.00+18.40%2021-11-18
Anonymous
Barclays
Strong BuyMaintains$240.00+7.64%2021-11-05
Credit Suisse
Top 29%
72
BuyMaintains$230.00+3.15%2021-08-09
Barclays
Bottom 10%
10
Strong BuyMaintains$235.00+5.40%2021-08-06
Raymond James
Bottom 10%
10
HoldDowngradesN/AN/A2021-07-16
Argus Research
Top 14%
87
Strong BuyMaintains$195.00-12.54%2021-05-28
Citigroup
Top 43%
58
HoldMaintains$184.00-17.48%2021-05-12
Bank of America
Bottom 10%
10
Strong BuyUpgrades$180.00-19.27%2021-03-08

1 of 1

Forecast return on equity

Is ZTS forecast to generate an efficient return?
Company
65.73%
Industry
91.37%
Market
37.06%
ZTS's Return on Equity is forecast to be high in 3 years (65.73%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ZTS forecast to generate an efficient return on assets?
Company
22.44%
Industry
77.04%
ZTS is forecast to generate lower Return on Assets (22.44%) than the US Drug Manufacturers - Specialty & Generic industry average (77.04%)
Forecast

ZTS earnings per share forecast

What is ZTS's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$4.53+8.63%
Avg 2 year Forecast
$5.13+23.02%
Avg 3 year Forecast
$5.94+42.45%
ZTS's earnings are forecast to grow at a rate of 12.16% per year, which is not exceptional
Forecast

ZTS revenue forecast

What is ZTS's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$7.7B+1.51%
Avg 2 year Forecast
$8.4B+10.69%
Avg 3 year Forecast
$9.1B+19.77%
ZTS's revenue is forecast to grow at a rate of 6.2% per year, which is not exceptional
Forecast

ZTS earnings growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
12.16%
Industry
27.82%
Market
14.37%
ZTS's earnings are forecast to grow slower (12.16% per year) than the US Drug Manufacturers - Specialty & Generic industry average (27.82%)
Forecast
ZTS's earnings are forecast to grow slower (12.16% per year) than the US market average (14.37%)
Forecast
ZTS's earnings are forecast to grow faster (12.16% per year) than the risk-free savings rate (1.4%)
Forecast

ZTS revenue growth forecast

How is ZTS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
6.2%
Industry
24.36%
Market
10.03%
ZTS's revenues are forecast to grow slower (6.2% per year) than the US Drug Manufacturers - Specialty & Generic industry average (24.36%)
Forecast
ZTS's revenues are forecast to grow slower (6.2% per year) than the US market average (10.03%)
Forecast

Zoetis Stock Forecast FAQ

Is Zoetis Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: ZTS) stock is to Strong Buy ZTS stock.

Out of 7 analysts, 4 (57.14%) are recommending ZTS as a Strong Buy, 1 (14.29%) are recommending ZTS as a Buy, 2 (28.57%) are recommending ZTS as a Hold, 0 (0%) are recommending ZTS as a Sell, and 0 (0%) are recommending ZTS as a Strong Sell.

What is ZTS's earnings growth forecast for 2021-2023?

(NYSE: ZTS) Zoetis's forecast annual earnings growth rate of 12.16% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 27.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Zoetis's earnings in 2021 is $1,982,000,000.On average, 9 Wall Street analysts forecast ZTS's earnings for 2021 to be $2,143,259,974, with the lowest ZTS earnings forecast at $2,124,334,941, and the highest ZTS earnings forecast at $2,152,722,490. On average, 9 Wall Street analysts forecast ZTS's earnings for 2022 to be $2,427,135,467, with the lowest ZTS earnings forecast at $2,318,316,528, and the highest ZTS earnings forecast at $2,540,685,664.

In 2023, ZTS is forecast to generate $2,810,367,383 in earnings, with the lowest earnings forecast at $2,630,579,570 and the highest earnings forecast at $3,009,080,228.

What is ZTS's revenue growth forecast for 2021-2023?

(NYSE: ZTS) Zoetis's forecast annual revenue growth rate of 6.2% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 24.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.03%.

Zoetis's revenue in 2021 is $7,616,000,000.On average, 6 Wall Street analysts forecast ZTS's revenue for 2021 to be $3,657,899,904,542, with the lowest ZTS revenue forecast at $3,637,620,785,560, and the highest ZTS revenue forecast at $3,666,564,257,721. On average, 6 Wall Street analysts forecast ZTS's revenue for 2022 to be $3,988,490,422,029, with the lowest ZTS revenue forecast at $3,874,427,356,358, and the highest ZTS revenue forecast at $4,072,083,711,637.

In 2023, ZTS is forecast to generate $4,315,767,639,384 in revenue, with the lowest revenue forecast at $4,145,528,452,364 and the highest revenue forecast at $4,432,242,700,496.

What is ZTS's forecast return on assets (ROA) for 2021-2024?

(NYSE: ZTS) forecast ROA is 22.44%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 77.04%.

What is ZTS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ZTS price target, the average ZTS price target is $214.67, with the highest ZTS stock price forecast at $264.00 and the lowest ZTS stock price forecast at $180.00.

On average, Wall Street analysts predict that Zoetis's share price could stay at $214.67 by Nov 18, 2022. The average Zoetis stock price prediction forecasts a potential downside of N/A from the current ZTS share price of $222.97.

What is ZTS's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ZTS) Zoetis's current Earnings Per Share (EPS) is $4.17. On average, analysts forecast that ZTS's EPS will be $4.53 for 2021, with the lowest EPS forecast at $4.49, and the highest EPS forecast at $4.55. On average, analysts forecast that ZTS's EPS will be $5.13 for 2022, with the lowest EPS forecast at $4.90, and the highest EPS forecast at $5.37. In 2023, ZTS's EPS is forecast to hit $5.94 (min: $5.56, max: $6.36).

What is ZTS's forecast return on equity (ROE) for 2021-2024?

(NYSE: ZTS) forecast ROE is 65.73%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.